Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Phosphoinositide 3-kinases (PI3Ks) are crucial regulators of cellular processes vital for cancer progression.
• Class I PI3Ks include four isoforms: p110α, p110β, p110γ, and p110δ, with increasing evidence for roles beyond p110α.
• The p110γ isoform has emerged as a significant factor in cancer development and progression.

Purpose of the Study:

• To investigate the role of PI3Kγ in gastrointestinal tumor development and progression.
• To explore the potential of targeting PI3Kγ as a therapeutic strategy for aggressive cancers like pancreatic ductal adenocarcinoma (PDAC) and hepatocellular carcinoma (HCC).

Main Methods:

• Analysis of PI3Kγ expression in human PDAC and HCC tissues versus normal counterparts.
• Assessment of the effects of selective PI3Kγ inhibition on cancer cell proliferation.
• Review of existing literature on PI3Kγ's role in tumor microenvironment, immune response, angiogenesis, and cell migration.

Main Results:

• Specific overexpression of PI3Kγ was identified in human PDAC and HCC tissues.
• Selective PI3Kγ inhibition effectively blocked PDAC and HCC cell proliferation.
• PI3Kγ influences cancer cell interactions with the tumor microenvironment, including immune cell invasion and angiogenesis.

Conclusions:

• PI3Kγ plays multifaceted roles in tumor progression and metastasis.
• Targeting PI3Kγ offers a promising multi-pronged therapeutic approach against aggressive gastrointestinal tumors.
• Pharmacological inhibition of PI3Kγ directly impacts tumor growth and related processes.